HIV ribozyme gene therapy - Immusol

Drug Profile

HIV ribozyme gene therapy - Immusol

Alternative Names: HIVase 1

Latest Information Update: 26 Sep 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Immusol; University of California, San Diego
  • Class Antivirals; Gene therapies; Ribozyme genes
  • Mechanism of Action Ribonuclease stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 26 Sep 2006 Discontinued - Phase-I for HIV infections treatment in USA (Parenteral)
  • 10 Jul 2002 This programme is still in active development
  • 17 Feb 1999 Phase-I clinical trials for HIV infections treatment in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top